Medical device giant Medtronic announced plans to acquire SPR Therapeutics for 650 million dollars. Consequently, this strategic acquisition aims to expand non-invasive chronic pain treatment options for patients worldwide. Medtronic will gain access to the innovative SPRINT peripheral nerve stimulation system. Thus, healthcare providers can offer temporary relief without permanent implants.
A Shift in Chronic Pain Treatment
Indeed, chronic pain affects millions of adults globally. Clinicians constantly search for effective, non-opioid solutions to manage this debilitating condition. Fortunately, the SPRINT system provides a temporary, 60-day therapy. Furthermore, the FDA-cleared device integrates smoothly into existing clinical workflows. As a result, physicians can intervene much earlier in the patient care pathway.
How the SPRINT PNS System Works
Unlike traditional neurostimulators, this technology does not require a permanent surgical implant. Specifically, a physician places a micro-lead percutaneously to stimulate target peripheral nerves. Patients then receive electrical stimulation for two months to relieve their pain. Ultimately, this approach minimizes surgical risks and reduces reliance on opioid medications.
Frequently Asked Questions
Q1: How does the SPRINT PNS System provide pain relief?
The system uses temporary peripheral nerve stimulation to target specific nerve fibers. Specifically, it delivers mild electrical pulses through a micro-lead for 60 days to disrupt pain signals without needing a permanent implant.
Q2: Why is Medtronic acquiring SPR Therapeutics?
Medtronic wants to expand its neuromodulation portfolio with minimally invasive, non-opioid therapies. Consequently, this acquisition allows the company to reach patients much earlier in their chronic pain journey.
References
- Medtronic plans to buy SPR Therapeutics for $650 million to expand paintreatment options – ETHealthworld
- Medtronic plc. Medtronic announces intent to acquire SPR Therapeutics, Inc., expanding care options for people living with chronic pain. PR Newswire. May 20, 2026.
Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.